Evidence map›Paper›PMID 41383156›Full record

ArticleAnnals of medicine2025

AI-driven prediction of severe respiratory sequelae in COVID-19 patients.

Yao Li, Lihua Liao, Xianyue Hu, Lufang Huang, Lin Zhang

Abstract read
In one paragraph

Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yao LiLiuzhou People's Hospital, Liuzhou, Guangxi, P. R. China.
Lihua LiaoLiuzhou People's Hospital, Liuzhou, Guangxi, P. R. China.
Xianyue HuLiuzhou People's Hospital, Liuzhou, Guangxi, P. R. China.
Lufang HuangLiuzhou People's Hospital, Liuzhou, Guangxi, P. R. China.
Lin ZhangLiuzhou People's Hospital, Liuzhou, Guangxi, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn coronavirus disease 2019 (COVID-19) patients, respiratory sequelae are common complications that significantly impact health outcomes. Hence, early identification of patients at risk is essential for improving prognosis and care. MATERIALS AND

methodsWe enrolled 516 COVID-19 patients and applied K-means algorithms to cluster them into subtypes based on clinical characteristics and risk profiles. ResNet-50 was employed to analyze and extract features from chest X-rays, accurately identifying COVID-19-related lesions. The extracted imaging data were integrated with clinical data to develop a predictive model aimed at stratifying post-COVID-19 patients by risk and identifying those likely to develop severe respiratory sequelae.

resultsWe identified two distinct COVID-19 subtypes, one of which was associated with severe respiratory sequelae. The convolutional neural networks (CNNs) accurately detected COVID-19-related lesions on chest X-rays. The predictive model showed excellent subtype discriminative ability, achieving an area under the curve (AUC) of 0.949 and 0.958 in the training and validation cohorts, respectively.

conclusionsOur AI-driven predictive model demonstrates strong potential for the early identification of respiratory sequelae in COVID-19 patients. By applying the K-means algorithm to cluster patients based on clinical characteristics, in combination with feature extraction from chest X-rays using the ResNet-50 deep learning model, we accurately stratified patients by their risk of severe respiratory outcomes. However, to evaluate its performance in clinical settings, further validation using larger, independent datasets is essential to confirm the model's reliability and generalizability across diverse populations.

Indexed as

Artificial IntelligenceCOVID-19AdultAgedAlgorithmsFemaleHumansLungMaleMiddle AgedNeural Networks, ComputerPrognosisSARS-CoV-2Severity of Illness Indexconvolutional neural networksCOVID-19precision medicinerespiratory sequelaeunsupervised machine learning

Identifiers

PMID41383156
PMCPMC12704136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.